A: Objective Response Group
B: Non-Objective Response Group
Figure 2: Cumulative survival rates according to the responses of advanced HCC after 2nd cycle and 4th cycle of HAIC. A) Among 54 patients (of whom 17 were in the objective response group after 2nd cycle of HAIC and 37 were in the non-objective response group after 2nd cycle of HAIC), the median overall survival was 190 days (6.3 months) in the objective response group, as compared with 96 days (3.2 months) in the non-objective response group (p = 0.265). B) Among 54 patients (of whom 9 objective response group and 12 non-objective response group after 4th cycle of HAIC and 33 non-objective response group after 2nd cycle of HAIC), the median overall survival was 302 days (10.1 months) in objective response group, as compared with 111 days (3.7 months) in non-objective response group (p = 0.009). HAIC: Hepatic Arterial Infusion Chemotherapy.